Fmoc-L-Pro-CHN2

Fmoc-L-Pro-CHN2 is an Fmoc-protected, L-configured proline derivative bearing a terminal diazomethyl (CHN2) functional group on the side chain, classifying it as a protected amino acid suitable for peptide-related synthesis. The molecule contains an Fmoc carbamate protecting group on the α-amino functionality and a free carboxyl group, while the ring-constrained proline framework provides a secondary amide-like backbone geometry and positions the CHN2 substituent for chemical handling. In synthesis, the protected amino acid form supports stepwise incorporation into peptide intermediates under conditions that remove the Fmoc group to expose the amino functionality, and the diazomethyl handle enables downstream derivatization or labeling workflows that use diazo-containing reagents.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25576

CAS No:201864-70-2

Synonyms/Alias:AmbotzFAA1600;MolPort-008-267-696;201864-70-2

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-prolinyl-diazomethane, (S)-2-Diazoacetyl-pyrrolidine-1-carboxylic acid (9-fluorenylmethyl) ester

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H19N3O3
M.W/Mr.
361,4 g/mole

Fmoc-L-Pro-CHN2 is an Fmoc-protected L-proline diazomethyl ketone derivative in which the proline ring provides a conformationally constrained secondary amine backbone while the CHN2 functionality introduces a diazo group suitable for controlled reactivity. The molecule contains an N-fluorenylmethoxycarbonyl (Fmoc) protecting group on the stereodefined proline nitrogen, a carboxyl-equivalent masked as part of the proline framework, and a chiral center at the proline α-position that governs stereochemical outcomes during peptide coupling and subsequent transformations. The diazo moiety can participate in carbene-generation chemistry under appropriate conditions, enabling downstream conversion into carbon-carbon bond-forming motifs and functionalized analogs without losing the proline scaffold. The combination of a peptide-compatible N-protection handle and a reactive diazo functional group makes Fmoc-L-Pro-CHN2 a practical chiral amino acid intermediate for constructing labeled or structurally modified peptide building blocks.

1. Peptide Synthesis

Fmoc-L-Pro-CHN2 is applied in peptide synthesis workflows where Fmoc deprotection and standard amide bond formation enable incorporation of a diazo-functional proline unit into peptide chains. The proline ring contributes conformational constraint and secondary amide geometry, while the Fmoc group supports orthogonal protection strategies compatible with solid-phase peptide synthesis and solution-phase coupling. The diazo functionality can be retained through coupling steps and then converted post-assembly to generate peptide analogs bearing new carbon frameworks or side-chain modifications derived from carbene chemistry. The resulting diazo-bearing peptide products can be used as intermediates for structure-activity relationship studies and for building stereochemically defined peptidomimetics from a single chiral amino acid precursor.

2. Peptidomimetic Construction

Fmoc-L-Pro-CHN2 is used for peptidomimetic construction in medicinal chemistry and molecular design programs that require proline-containing scaffolds with appended carbon-carbon bond motifs. The stereogenic proline α-center and the cyclic ring topology influence backbone conformation, while the diazo group provides a handle for generating reactive intermediates that can be transformed into substituted carbons or ring-embedded functionalities. Fmoc protection allows controlled handling during synthesis and enables sequential derivatization strategies where the diazo group can be activated after peptide assembly or after fragment coupling. Downstream products can serve as analog libraries for SAR studies, enabling systematic exploration of how proline conformational effects and diazo-derived substituents impact molecular recognition.

3. Chemical Biology Labeling

Fmoc-L-Pro-CHN2 supports chemical biology labeling strategies that rely on installing reactive diazo-derived functionalities into peptide or protein fragments for subsequent conjugation chemistry. The Fmoc-protected proline unit can be incorporated into peptide tags, affinity handles, or probe precursors, while the diazo group can be converted into reactive carbon-centered species that enable covalent capture of nearby nucleophiles under controlled conditions. The constrained proline backbone can improve placement geometry of the reactive handle within a peptide context, which can be relevant for mapping interaction surfaces or generating site-defined labeling reagents. The compound thus functions as a chiral amino acid intermediate for producing diazo-enabled probes and for generating labeled biomolecule fragments used in biochemical research workflows.

4. Process Chemistry Intermediate

Fmoc-L-Pro-CHN2 is relevant to process chemistry intermediate preparation where protection management and controlled reactivity are central to scalable synthesis planning. The Fmoc group provides a well-defined, base-labile protecting strategy that can be integrated into manufacturing routes that require stepwise assembly of protected amino acid derivatives and peptide building blocks. The diazo functionality introduces a transformation step that can be scheduled after key coupling or purification operations, supporting route design that separates diazo activation from earlier handling stages. The proline stereochemistry and the single reactive diazo site can simplify downstream conversion into defined functionalized derivatives, making the compound suitable for fine chemical synthesis of diazo-containing chiral intermediates.

5. Analytical Research Standards

Fmoc-L-Pro-CHN2 is used in analytical research for developing reference materials and method validation standards related to diazo-functional amino acid derivatives and Fmoc-protected peptide building blocks. The combination of a stable Fmoc chromophore and a stereodefined proline framework provides identifiable signals for LC-MS and related analytical techniques, while the diazo group can be used to generate characteristic transformation products for method specificity. The compound's defined structure supports calibration and impurity profiling when monitoring Fmoc deprotection, peptide coupling, or post-coupling diazo conversion steps in research-grade workflows. Analytical standards derived from Fmoc-L-Pro-CHN2 can therefore support routine characterization of amino acid derivatization processes and peptide synthesis intermediates used in biochemical and synthetic chemistry laboratories.

Size
1 g;
InChI
1S/C21H19N3O3/c22-23-12-20(25)19-10-5-11-24(19)21(26)27-13-18-16-8-3-1-6-14(16)15-7-2-4-9-17(15)18/h1-4,6-9,12,18-19H,5,10-11,13H2/b20-12+/t19-/m0/s1
InChI Key
IWVACDCSYKSLKI-GUBFPNNNSA-N
Canonical SMILES
C1CC(N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=C[N+]#N)[O-]

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Synthesis ServicesCustom Conjugation ServicePeptide Analysis ServicesPeptide CDMOEpitope Mapping ServicescGMP Peptide ServicePeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers